AEG-1 is highly expressed in advanced endometrial cancer cells, and knocking down AEG-1 in endometrial cancer cells increased the sensitivity to tumor necrosis factor-α-related apoptosis-inducing ligand (TRAIL) and histone deacetylase (HDAC) inhibitor LBH589 [226]. Here, HDAC9 is linked to endometrial cancer.